1. Home
  2. SFNC vs WGS Comparison

SFNC vs WGS Comparison

Compare SFNC & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simmons First National Corporation

SFNC

Simmons First National Corporation

N/A

Current Price

$23.12

Market Cap

3.3B

Sector

Finance

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$97.44

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SFNC
WGS
Founded
1903
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.7B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
SFNC
WGS
Price
$23.12
$97.44
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$22.17
$120.71
AVG Volume (30 Days)
1.0M
456.0K
Earning Date
04-16-2026
05-04-2026
Dividend Yield
4.05%
N/A
EPS Growth
N/A
62.37
EPS
0.93
N/A
Revenue
N/A
$427,539,000.00
Revenue This Year
$2,607.90
$29.98
Revenue Next Year
$4.15
$25.92
P/E Ratio
$24.95
N/A
Revenue Growth
N/A
39.97
52 Week Low
$17.00
$32.21
52 Week High
$24.32
$170.87

Technical Indicators

Market Signals
Indicator
SFNC
WGS
Relative Strength Index (RSI) 51.77 70.63
Support Level $22.15 $81.37
Resistance Level $23.40 $94.82
Average True Range (ATR) 0.40 4.56
MACD 0.04 -0.11
Stochastic Oscillator 56.71 81.32

Price Performance

Historical Comparison
SFNC
WGS

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. Its loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: